Endothelins and Endothelin Receptor Antagonists: Therapeutic Considerations for a Novel Class of Cardiovascular Drugs

By T. Lüscher, M. Barton. Circulation, 2000

623 citations recorded by the source corpus.

Subfields: Biophysics, Cardiology and Cardiovascular Medicine, Physiology

View Paper: https://www.semanticscholar.org/paper/3ba0e39623fd9f3e2da569bb08c7635427e3018b

Citations in the corpus

• Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. (2012, neutral): “However, the bene fi t of activating pro-survival pathways is counteracted by the vasoconstrictive effects of endothelin-1 on the vasculature [96].”